Elite Pharmaceuticals Inc (ELTP)

[Couch]

Thanks but I actually prefer FACTS to compete BS.

Consolidated revenues for Fiscal 2016 were a record $12.5 million, an increase of approximately 150% over revenues of the prior year. This increase is due to across-the-board increases in both manufacturing revenues and license fees. Manufacturing revenues more than doubled from $3.8 million last year to $8.0 million in Fiscal 2016. The growth was from a strong, sustained and broad expansion in the sales of Elite's product revenues. License fees more than tripled from $1.1 million last year to $4.5 million in Fiscal 2016. This increase was from growth in of Elite's generic product fees and from development milestones for SequestOx™, the first of Elite's abuse-deterrent opioid products.